Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nat. Rev. Neurol. doi:10/1038/nrneurol

Published byNathan O’Connor’ Modified over 6 years ago

Similar presentations

Presentation on theme: "Nat. Rev. Neurol. doi:10/1038/nrneurol"— Presentation transcript:

1 Nat. Rev. Neurol. doi:10/1038/nrneurol.2016.2
Figure 1 Towards successful management of the complexity of multiple sclerosis (MS) Figure 1 | Towards successful management of the complexity of multiple sclerosis (MS). An understanding of the pathogenic mechanisms, progression, comorbidities and optimal treatment escalation is necessary to formulate a treatment plan for individuals with MS. Ciccarelli, O. & Thompson, A. (2016) Managing the complexity of multiple sclerosis Nat. Rev. Neurol. doi:10/1038/nrneurol

Download ppt "Nat. Rev. Neurol. doi:10/1038/nrneurol"

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 4 Progression-free survival, according to treatment group

Figure 4 Progression-free survival, according to treatment group
Figure 3 Life expectancy at birth in all countries included

Figure 3 Life expectancy at birth in all countries included
MRI and possible differentiating features with nonconventional MRI

MRI and possible differentiating features with nonconventional MRI
Figure 1 Perivenous distribution of multiple sclerosis lesions

Figure 1 Perivenous distribution of multiple sclerosis lesions
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 The US Centers for Disease Control and

Figure 2 The US Centers for Disease Control and
Figure 4 Time course of the development of physiological changes

Figure 4 Time course of the development of physiological changes
Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET
Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)

Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Proposed mechanism of Guillain–Barré

Figure 2 Proposed mechanism of Guillain–Barré
Figure 2 The new concept of prodromal RBD

Figure 2 The new concept of prodromal RBD
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol

Similar presentations

Ads by Google